Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival.

[1]  R. Ritch,et al.  The iridocorneal endothelial syndrome. , 2018, Survey of ophthalmology.

[2]  A. Kheirkhah,et al.  Management of high-risk corneal transplantation. , 2017, Survey of ophthalmology.

[3]  Xianqun Fan,et al.  Rabbit Model of Corneal Endothelial Injury Established Using the Nd: YAG Laser , 2017, Cornea.

[4]  N. Koizumi,et al.  Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases , 2017, Journal of ophthalmology.

[5]  S. Koh,et al.  Corneal Endothelial Cell Integrity in Precut Human Donor Corneas Enhanced by Autocrine Vasoactive Intestinal Peptide , 2017, Cornea.

[6]  S. Bonini,et al.  The Intriguing Role of Neuropeptides at the Ocular Surface. , 2017, The ocular surface.

[7]  R. Dana,et al.  Alloimmunity and Tolerance in Corneal Transplantation , 2016, The Journal of Immunology.

[8]  H. Başmak,et al.  Effect of vasoactive intestinal peptide on the wound healing of alkali-burned corneas. , 2016, International journal of ophthalmology.

[9]  Gilles Thuret,et al.  Global Survey of Corneal Transplantation and Eye Banking. , 2016, JAMA ophthalmology.

[10]  R. Elkitkat,et al.  Safety of Intracameral Injection of Minimal Bactericidal Concentration of Povidone Iodine on the Corneal Endothelium in a Rabbit Model , 2016, Cornea.

[11]  R. Dana,et al.  Ocular surgical models for immune and angiogenic responses. , 2015, Journal of biological methods.

[12]  N. Koizumi,et al.  Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study , 2015, PloS one.

[13]  R. Dana,et al.  Quantification of allospecific and nonspecific corneal endothelial cell damage after corneal transplantation , 2015, Eye.

[14]  A. Jun,et al.  Transcript profile of cellular senescence-related genes in Fuchs endothelial corneal dystrophy. , 2014, Experimental eye research.

[15]  G. Opelz,et al.  Role of human corneal endothelial cells in T-cell-mediated alloimmune attack in vitro. , 2014, Investigative ophthalmology & visual science.

[16]  F. Gao,et al.  Vasoactive Intestinal Peptide (VIP) Attenuates Mouse Liver Ischemia/Reperfusion Injury via cAMP-PKA Pathway , 2013 .

[17]  J. Mehta,et al.  A mouse model of corneal endothelial decompensation using cryoinjury , 2013, Molecular vision.

[18]  V. Chatzimavridou-Grigoriadou,et al.  Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics. , 2013, Hippokratia.

[19]  T. Nguyen,et al.  Telomerase Immortalization of Human Corneal Endothelial Cells Yields Functional Hexagonal Monolayers , 2012, PloS one.

[20]  M. Delgado,et al.  Potential applications of vasoactive intestinal Peptide-based therapies on transplantation. , 2012, Endocrine, metabolic & immune disorders drug targets.

[21]  B. Seitz,et al.  A new tool for the transfection of corneal endothelial cells: calcium phosphate nanoparticles. , 2012, Acta biomaterialia.

[22]  S. Koh.  Corneal endothelial autocrine trophic factor VIP in a mechanism-based strategy to enhance human donor cornea preservation for transplantation. , 2012, Experimental eye research.

[23]  M. Delgado,et al.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions , 2011, Amino Acids.

[24]  S. Koh,et al.  Corneal endothelial autocrine VIP enhances its integrity in stored human donor corneoscleral explant. , 2011, Investigative ophthalmology & visual science.

[25]  F. Fang,et al.  Vasoactive intestinal peptide protects alveolar epithelial cells against hyperoxia via promoting the activation of STAT3 , 2011, Regulatory Peptides.

[26]  W. Jiang,et al.  Inhibition of Toll-like receptor 4 with vasoactive intestinal peptide attenuates liver ischemia-reperfusion injury. , 2011, Transplantation proceedings.

[27]  B. Acar,et al.  Changes in endothelial cell density following penetrating keratoplasty and deep anterior lamellar keratoplasty. , 2011, International journal of ophthalmology.

[28]  N. Koizumi,et al.  Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. , 2009, Investigative ophthalmology & visual science.

[29]  S. Koh,et al.  VIP down‐regulates the inflammatory potential and promotes survival of dying (neural crest‐derived) corneal endothelial cells ex vivo: necrosis to apoptosis switch and up‐regulation of Bcl‐2 and N‐cadherin , 2009, Journal of neurochemistry.

[30]  A. Rutzen,et al.  VIP and VIP gene silencing modulation of differentiation marker N-cadherin and cell shape of corneal endothelium in human corneas ex vivo. , 2008, Investigative ophthalmology & visual science.

[31]  H. Beele,et al.  Graft failure: I. Endothelial cell loss , 2008, International Ophthalmology.

[32]  S. Bernstein,et al.  Vasoactive intestinal peptide induction by ciliary neurotrophic factor in donor human corneal endothelium in situ , 2007, Neuroscience Letters.

[33]  A. Dick,et al.  Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft rejection. , 2006, Experimental eye research.

[34]  E. Higginbotham,et al.  VIP Immunoreactivity in Human Aqueous Humor , 2005, Current eye research.

[35]  Sanjay V. Patel,et al.  Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. , 2005, Transactions of the American Ophthalmological Society.

[36]  D. Larkin,et al.  Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. , 2004, Investigative ophthalmology & visual science.

[37]  J. Forrester,et al.  Quantitative evaluation of the corneal endothelium in the mouse after grafting , 2004, British Journal of Ophthalmology.

[38]  R. Jensen,et al.  VIP as a trophic factor in the CNS and cancer cells , 2003, Peptides.

[39]  B. Yue,et al.  VIP Stimulation of cAMP Production in Corneal Endothelial Cells in Tissue and Organ Cultures , 2002, Cornea.

[40]  J. Waschek,et al.  Corneal endothelial cell survival in organ cultures under acute oxidative stress: effect of VIP. , 2000, Investigative ophthalmology & visual science.

[41]  E. Melamed,et al.  Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease 1 This manuscript is based on a poster presented at the Brain Research Interactive Symposium on “Neuropeptides at the Millennium”, Miami, October 1999. 1 , 2000, Brain Research.

[42]  J. Niederkorn.  The immune privilege of corneal allografts. , 1999, Transplantation.

[43]  J. Cooper,et al.  Vasoactive intestinal peptide ameliorates reperfusion injury in rat lung transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[44]  Jaipaul Singh,et al.  Control of porcine lacrimal gland secretion by non-cholinergic, non-adrenergic nerves: effects of electrical field stimulation, VIP and NPY , 1997, Brain Research.

[45]  M. Dana,et al.  Topical interleukin 1 receptor antagonist promotes corneal transplant survival. , 1997, Transplantation.

[46]  D. Dartt,et al.  Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells. , 1996, Experimental eye research.

[47]  I. Gozes,et al.  Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Cousins,et al.  Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. , 1994, Journal of immunology.

[49]  J. Streilein,et al.  ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLY , 1992, Transplantation.

[50]  K. Miyata,et al.  [Corneal endothelial cell damage in penetrating keratoplasty]. , 1992, Nippon Ganka Gakkai zasshi.

[51]  The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. , 1992, Archives of ophthalmology.

[52]  D. Musch,et al.  The effect of allograft rejection after penetrating keratoplasty on central endothelial cell density. , 1991, American journal of ophthalmology.

[53]  J. Nordmann,et al.  Autoradiographic characterization and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes. , 1991, Experimental eye research.

[54]  S. Podos,et al.  Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. , 1987, The Journal of pharmacology and experimental therapeutics.

[55]  R. Rosenberg,et al.  Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. , 1976, Science.

[56]  V. Mutt,et al.  Polypeptide with Broad Biological Activity: Isolation from Small Intestine , 1970, Science.

[57]  J. E. Robbins,et al.  The Human Corneal Endothelium , 1966 .